T1	Participants 111 166	Patients with myasthenia gravis receive pyridostigmine,
T2	Participants 218 312	These patients demonstrate a heightened sensitivity towards non-depolarising muscle relaxants.
T3	Participants 745 868	well-controlled adult patients with myasthenia gravis who were posted for thymectomy, were randomly divided into two groups
T4	Participants 870 960	Patients in Group 1 received their last dose of pyridostigmine on the night before surgery
T5	Participants 1286 1372	Fourteen patients (7 in each group) belonging to both sexes were enrolled in the study
T6	Participants 1974 2005	patients with myasthenia gravis
